Alpine Immune Sciences Competitors and Similar CompaniesClear all

Alpine Immune Sciences's competitors and similar companies include Janssen, Loxo Oncology, Epizyme and Ascentage Pharma.
Alpine Immune Sciences
Alpine Immune Sciences
Alpine Immune Sciences is a biotechnology company that develops protein-based immunotherapies.
Janssen
Janssen
Janssen is a company providing prescription pharmaceutical products.
Loxo Oncology
Loxo Oncology
Loxo Oncology is a biopharmaceutical company focused on targeted cancer therapies for genetically-defined patient populations.
Epizyme
Epizyme
Epizyme is a clinical stage biopharmaceutical company focusing on treatments for blood cancer and tumors.
Ascentage Pharma
Ascentage Pharma
Ascentage Pharma Group International (亚盛闘棄集團) is a biopharmaceutical company that is engaged in discovering, developing, and commercializing therapies.
Founding Date
Founding Date
2015
Founding Date
1953
Founding Date
2013
Founding Date
2007
Founding Date
2017
Type
Type
Subsidiary
Type
Subsidiary
Type
Subsidiary
Type
Public
Type
Public
Tags
Locations
Locations
Seattle, US HQ
Locations
Raritan, US HQ
Vienna, AT
Prague, CZ
Espoo, FI
Budapest, HU
Oslo, NO
Belgrade, RS
see more
Locations
Stamford, US HQ
Alcobendas, ES
Boulder, US
New York, US
South San Francisco, US
Locations
Cambridge, US HQ
Locations
Suzhou, CN HQ
Guangzhou Shi, CN
Suzhou Shi, CN
Taizhou, CN
Rockville, US
Employees
Employees
484% decrease
Employees
17,3684% decrease
Employees
65610% decrease
Employees
20364% increase
Employees
567

Financial

Revenue (est.)
Revenue (est.)
$58.9m (FY, 2023)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$37.4m (FY, 2021)
Revenue (est.)
¥574.1m (FY, 2025)
Cost of goods
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
$10.5m (FY, 2021)
Cost of goods
¥48.9m (FY, 2025)
Net income
Net income
($32.2m) (FY, 2023)
Net income
N/A
Net income
($148.9m) (FY, 2017)
Net income
($251.1m) (FY, 2021)
Net income
(¥1.2b) (FY, 2025)

Funding

Total funding raised
Total funding raised
$ 49.3m
Total funding raised
N/A
Total funding raised
$ 57m
Total funding raised
$ 51.5m
Total funding raised
$ 237.5m
For sources of this data, please see the company profile

View Company Profiles

Janssen
HQ
Raritan, US

Janssen is a company providing prescription pharmaceutical products.

View company
Loxo Oncology
HQ
Stamford, US

Loxo Oncology is a biopharmaceutical company focused on targeted cancer therapies for genetically-defined patient populations.

View company
Epizyme
HQ
Cambridge, US
Employees
203

Epizyme is a clinical stage biopharmaceutical company focusing on treatments for blood cancer and tumors.

View company
Ascentage Pharma
HQ
Suzhou, CN
Employees
567

Ascentage Pharma Group International (亚盛闘棄集團) is a biopharmaceutical company that is engaged in discovering, developing, and commercializing therapies.

View company